PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)

$143.73 3.82 (2.7303%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 69

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) News Sources

Psoriatic Arthritis Market Landscape: 6 Key Late-Stage Drugs Set to Drive Future Growth | DelveInsight

21-09-2026

yahoo.com

external link

Silence Therapeutics' Divesiran Data Support Best-in-Class Potential, Morgan Stanley Says

11-08-2026

yahoo.com

external link

FDA OKs Takeda, Protagonist drug for rare blood cancer

31-08-2026

biopharmadive.com

external link

Protagonist Therapeutics Reports Granting of Inducement Awards

18-08-2026

yahoo.com

external link

Protagonist Wins FDA Approval for MIMRYLO in Rare Blood Cancer Treatment

31-08-2026

marketbeat.com

external link

Protagonist Therapeutics (PTGX) Could Be 63% Below Fair Value After Investor Update Call

01-09-2026

yahoo.com

external link

The Bull Case For Protagonist Therapeutics (PTGX) Could Change Following FDA Approval Of MIMRYLO And Takeda Milestones

01-09-2026

yahoo.com

external link

MIMRYLO Approval Triggered $275M Payments for Protagonist (PTGX). Are Royalties the Better Commercial Model?

04-09-2026

yahoo.com

external link

Protagonist (PTGX) Swings To A Profit As Two Drugs Near Blockbuster Status

06-09-2026

yahoo.com

external link

Protagonist Therapeutics Announces $300 Million Share Repurchase Program

08-09-2026

yahoo.com

external link

PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) Sentiment Trend

0 25 50 75 100 88 78 92 54 79 81 75 52 8 85 21-09-2026 11-08-2026 31-08-2026 18-08-2026 01-09-2026 04-09-2026 06-09-2026 08-09-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) FAQs

toggle

What is the current price of PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)?

The current price of PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) is $143.73.


toggle

PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) absolute price change since previous trading day?

The absolute price change of PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) since the previous trading day is $3.82.


toggle

PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) percentage price change since previous trading day?

The percentage price change of PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) since the previous trading day is 2.7303%.


toggle

What is the most recent average sentiment score for PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)?

The most recent average sentiment score for PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) is 69 out of 100.


toggle

What is the most recent average sentiment for PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)?

The most recent sentiment for PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ) is .


SEC-8K** Filing Available For PROTAGONIST THERAPEUTICS INC (PTGX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

PTIX (Protagenic Therapeutics Inc)
TGTX (Tg Therapeutics)
TTRX (Turn Therapeutics Inc)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.